Back to all studies
OngoingEUCTR 2016-000709-36

Research into Antipsychotic Discontinuation and Reduction (RADAR): A Randomised Controlled Trial

This ongoing study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, View results.

SchizophreniaOther
In plain English

Key information made simple

This study is looking at care and outcomes for people with Schizophrenia, delusional disorders, schizoaffective disorder, psychosis or Elderly. Direct benefit is not guaranteed, but the study may help researchers improve future care.

What to expect

Your next step

The official record does not clearly describe the visit format, so the practical details are best checked directly in the source. Participation appears to involve study activities and follow-up chosen by the research team. The main fit and exclusions are best confirmed in the eligibility section of the official record. The phase details are not clearly stated here.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Need help deciding?

Ask HopeStage to review this study with me

This form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.

Loading the security check...
Study reference: EUCTR 2016-000709-36. We only ask for your email here. HopeStage can help you review the study, but this is not a medical eligibility decision.
In practice

For you

Taking part may help improve understanding of your condition.

It requires regular follow-up, often through questionnaires or interviews.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com